세계의 상처용 젤 시장 규모, 점유율, 동향 분석 : 제품별, 항균 특성별, 용도별, 최종 용도별, 구입 형태별, 유통 채널별, 지역별, 부문별 예측(2025-2033년)

Wound Gel Market Summary

The global wound gel market size was valued at USD 6.05 billion in 2024 and is projected to reach USD 9.68 billion by 2033, growing at a CAGR of 5.37% from 2025 to 2033. The demand for wound gel is rising owing to the increasing number of surgical cases and the growing burden of wounds.

According to the data published by the University of Hawaiʻi in February 2025, chronic wounds affect about 6.5 million individuals in the U.S. each year, contributing to an estimated USD 25 billion in healthcare costs. Such a high burden of wounds and growing healthcare expenditure globally is anticipated to drive the demand for wound gel in the coming years.

The rising number of surgical procedures worldwide is a significant driver for expanding the wound gels market. Surgical interventions often result in acute wounds that require effective post-operative care to minimize infection risk and promote faster healing. Advanced wound care products, particularly wound gels, are increasingly preferred due to their ability to maintain a moist wound environment, support autolytic debridement, and accelerate tissue regeneration. According to data published in the BMC Surgery journal in 2025, approximately 313 million surgical procedures are performed globally annually. This substantial volume underscores the growing demand for reliable and effective wound care solutions, reinforcing the critical role of wound gels in the post-surgical healing process.

In addition to traditional medical surgeries, the growing demand for cosmetic and plastic surgeries is expected to contribute significantly to the market's expansion.According to the 2023 Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, there was a 5% increase in overall cosmetic procedures from 2022 to 2023, as illustrated in the graph below:

Wound gels play a vital role in post-operative care following cosmetic procedures. These gels are designed to manage incisions and minor surgical wounds by promoting moist wound healing, which helps reduce the risk of scarring, minimizes the chance of infection, and accelerates tissue regeneration. As a result, wound gels are becoming essential in both in-clinic post-surgical protocols and at-home aftercare routines within aesthetic medicine. With the high volume of cosmetic surgeries, the demand for wound gels is expected to rise accordingly.

Global Wound Gel Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global wound gel market report based on product, antimicrobial properties, application, mode of purchase, distribution channel, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Dressings
  • Hydrogel dressing
  • Gelling fiber dressings
  • Others
• Gels
• Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
• Silver (Ag+)
• Non-Silver
• Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
• Prescription
• Non-prescription
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Offline
• Online
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Chronic Wounds
  • Diabetic Foot Ulcers (DFUs)
  • Pressure Ulcers
  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4
  • Leg Ulcers
• Acute Wounds
  • Surgical Incisions
  • Burns
  • 1st Degree
  • 2nd Degree
  • 3rd Degree
  • Lacerations, Abrasions
• End Use Outlook (Revenue, USD Million, 2021-2033)
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers
• Homecare Settings
• Long-Term Care Facilities
• Others
• Regional Outlook (Revenue, USD Million, 2021-2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Antimicrobial Properties
  • 1.1.3. Application
  • 1.1.4. Mode of Purchase
  • 1.1.5. Distribution Channel
  • 1.1.6. End-use
  • 1.1.7. Regional scope
  • 1.1.8. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Wound Gel Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of surgical procedures
    • 3.2.1.2. Rising burden of wounds
    • 3.2.1.3. Introduction of innovative and advanced wound gel
    • 3.2.1.4. Growing shift towards antimicrobial products
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Recalls of wound gel
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Improvements in public and private healthcare infrastructure
    • 3.2.3.3. Growth potential in emerging economies in the wound gel market
    • 3.2.3.4. Rising number of road accidents and sports injuries
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Potential complications and risks associated with wound gel
• 3.3. Wound Gel Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Wound Gel Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Wound Gel Market Product Movement Analysis
• 4.3. Global Wound Gel Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Dressings
  • 4.4.1. Dressings market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.1. Hydrogel dressings
      • 4.4.1.1.1. Hydrogel dressings market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.2. Gelling fiber dressings
      • 4.4.1.2.1. Gelling fiber dressings market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.3. Others
      • 4.4.1.3.1. Other market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Gels
  • 4.5.1. Gels market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Wound Gel Market Antimicrobial Properties Movement Analysis
• 5.3. Global Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
• 5.4. Silver
  • 5.4.1. Silvers market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Non Silver
  • 5.5.1. Non-silver market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Wound Gel Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Wound Gel Market Application Movement Analysis
• 6.3. Global Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Chronic Wounds
  • 6.4.1. Chronic wounds market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.4.1.1. Diabetic foot ulcers
      • 6.4.1.1.1. Diabetic foot ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.4.1.2. Pressure ulcers
      • 6.4.1.2.1. Pressure ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.4.1.2.1.1. Stage 1
          • 6.4.1.2.1.1.1. Stage 1 market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.4.1.2.1.2. Stage 2
          • 6.4.1.2.1.2.1. Stage 2 market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.4.1.2.1.3. Stage 3
          • 6.4.1.2.1.3.1. Stage 3 market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.4.1.2.1.4. Stage 4
          • 6.4.1.2.1.4.1. Stage 4 market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.4.1.3. Leg ulcers
      • 6.4.1.3.1. Leg ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.5. Acute Wounds
  • 6.5.1. Acute wounds market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.5.1.1. Surgical incisions
      • 6.5.1.1.1. Surgical incisions market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.5.1.2. Burns
      • 6.5.1.2.1. Burns market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.5.1.2.1.1. 1st degree burns
          • 6.5.1.2.1.1.1. 1st degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.5.1.2.1.2. 2nd degree burns
          • 6.5.1.2.1.2.1. 2nd degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
        • 6.5.1.2.1.3. 3rd degree burns
          • 6.5.1.2.1.3.1. degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.5.1.3. Lacerations & abrasions
      • 6.5.1.3.1. Lacerations & abrasions market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Wound Gel Market Mode of Purchase Movement Analysis
• 7.3. Global Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
• 7.4. Prescription
  • 7.4.1. Prescription market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.5. Non-prescription
  • 7.5.1. Non-prescription market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Wound Gel Market Distribution Channel Movement Analysis
• 8.3. Global Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
• 8.4. Offline
  • 8.4.1. Offline market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.5. Online
  • 8.5.1. Online market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 9. Wound Gel Devices: End Use Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Global Wound Gel Market End Use Movement Analysis
• 9.3. Global Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 9.4. Hospitals
  • 9.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
• 9.5. Specialty Clinics
  • 9.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
• 9.6. Ambulatory Surgery Centers
  • 9.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 9.7. Homecare Settings
  • 9.7.1. Homecare settings market estimates and forecasts for 2021 to 2033 (USD Million)
• 9.8. Long-Term Care Facilities
  • 9.8.1. Long-term care facilities market estimates and forecasts for 2021 to 2033 (USD Million)
• 9.9. Others
  • 9.9.1. Other market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 10. Wound Gel Market: Regional Estimates & Trend Analysis

• 10.1. Regional Dashboard
• 10.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 10.3. North America
  • 10.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 10.3.2. U.S.
    • 10.3.2.1. Key country dynamics
    • 10.3.2.2. Competitive scenario
    • 10.3.2.3. Regulatory framework
    • 10.3.2.4. Reimbursement scenario
    • 10.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 10.3.3. Canada
    • 10.3.3.1. Key country dynamics
    • 10.3.3.2. Competitive scenario
    • 10.3.3.3. Regulatory framework
    • 10.3.3.4. Reimbursement scenario
    • 10.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 10.3.4. Mexico
    • 10.3.4.1. Key country dynamics
    • 10.3.4.2. Competitive scenario
    • 10.3.4.3. Regulatory framework
    • 10.3.4.4. Reimbursement scenario
    • 10.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 10.4. Europe
  • 10.4.1. UK
    • 10.4.1.1. Key country dynamics
    • 10.4.1.2. Competitive scenario
    • 10.4.1.3. Regulatory framework
    • 10.4.1.4. Reimbursement scenario
    • 10.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 10.4.2. Germany
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Competitive scenario
    • 10.4.2.3. Regulatory framework
    • 10.4.2.4. Reimbursement scenario
    • 10.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 10.4.3. France
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. Competitive scenario
    • 10.4.3.3. Regulatory framework
    • 10.4.3.4. Reimbursement scenario
    • 10.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 10.4.4. Italy
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Competitive scenario
    • 10.4.4.3. Regulatory framework
    • 10.4.4.4. Reimbursement scenario
    • 10.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 10.4.5. Spain
    • 10.4.5.1. Key country dynamics
    • 10.4.5.2. Competitive scenario
    • 10.4.5.3. Regulatory framework
    • 10.4.5.4. Reimbursement scenario
    • 10.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 10.4.6. Denmark
    • 10.4.6.1. Key country dynamics
    • 10.4.6.2. Competitive scenario
    • 10.4.6.3. Regulatory framework
    • 10.4.6.4. Reimbursement scenario
    • 10.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 10.4.7. Sweden
    • 10.4.7.1. Key country dynamics
    • 10.4.7.2. Competitive scenario
    • 10.4.7.3. Regulatory framework
    • 10.4.7.4. Reimbursement scenario
    • 10.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 10.4.8. Norway
    • 10.4.8.1. Key country dynamics
    • 10.4.8.2. Competitive scenario
    • 10.4.8.3. Regulatory framework
    • 10.4.8.4. Reimbursement scenario
    • 10.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 10.5. Asia Pacific
  • 10.5.1. Japan
    • 10.5.1.1. Key country dynamics
    • 10.5.1.2. Competitive scenario
    • 10.5.1.3. Regulatory framework
    • 10.5.1.4. Reimbursement scenario
    • 10.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 10.5.2. India
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. Competitive scenario
    • 10.5.2.3. Regulatory framework
    • 10.5.2.4. Reimbursement scenario
    • 10.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 10.5.3. China
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. Competitive scenario
    • 10.5.3.3. Regulatory framework
    • 10.5.3.4. Reimbursement scenario
    • 10.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 10.5.4. South Korea
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Competitive scenario
    • 10.5.4.3. Regulatory framework
    • 10.5.4.4. Reimbursement scenario
    • 10.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 10.5.5. Australia
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. Competitive scenario
    • 10.5.5.3. Regulatory framework
    • 10.5.5.4. Reimbursement scenario
    • 10.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 10.5.6. Thailand
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Competitive scenario
    • 10.5.6.3. Regulatory framework
    • 10.5.6.4. Reimbursement scenario
    • 10.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 10.6. Latin America
  • 10.6.1. Brazil
    • 10.6.1.1. Key country dynamics
    • 10.6.1.2. Competitive scenario
    • 10.6.1.3. Regulatory framework
    • 10.6.1.4. Reimbursement scenario
    • 10.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 10.6.2. Argentina
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Competitive scenario
    • 10.6.2.3. Regulatory framework
    • 10.6.2.4. Reimbursement scenario
    • 10.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 10.7. MEA
  • 10.7.1. South Africa
    • 10.7.1.1. Key country dynamics
    • 10.7.1.2. Competitive scenario
    • 10.7.1.3. Regulatory framework
    • 10.7.1.4. Reimbursement scenario
    • 10.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 10.7.2. Saudi Arabia
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Competitive scenario
    • 10.7.2.3. Regulatory framework
    • 10.7.2.4. Reimbursement scenario
    • 10.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 10.7.3. UAE
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. Competitive scenario
    • 10.7.3.3. Regulatory framework
    • 10.7.3.4. Reimbursement scenario
    • 10.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 10.7.4. Kuwait
    • 10.7.4.1. Key country dynamics
    • 10.7.4.2. Competitive scenario
    • 10.7.4.3. Regulatory framework
    • 10.7.4.4. Reimbursement scenario
    • 10.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis, By Key Market Participants
• 11.2. Company/Competition Categorization
  • 11.2.1. Innovators
• 11.3. Vendor Landscape
  • 11.3.1. List of key distributors and channel partners
  • 11.3.2. Key customers
  • 11.3.3. Global Key company market share analysis, 2024
  • 11.3.4. Coloplast Ltd
    • 11.3.4.1. Company overview
    • 11.3.4.2. Financial performance
    • 11.3.4.3. Product benchmarking
    • 11.3.4.4. Strategic initiatives
  • 11.3.5. Medline Industries, LP
    • 11.3.5.1. Company overview
    • 11.3.5.2. Financial performance
    • 11.3.5.3. Product benchmarking
    • 11.3.5.4. Strategic initiatives
  • 11.3.6. Molnlycke Health Care AB
    • 11.3.6.1. Company overview
    • 11.3.6.2. Financial performance
    • 11.3.6.3. Product benchmarking
    • 11.3.6.4. Strategic initiatives
  • 11.3.7. Solventum
    • 11.3.7.1. Company overview
    • 11.3.7.2. Financial performance
    • 11.3.7.3. Product benchmarking
    • 11.3.7.4. Strategic initiatives
  • 11.3.8. Convatec Inc.
    • 11.3.8.1. Company overview
    • 11.3.8.2. Financial performance
    • 11.3.8.3. Product benchmarking
    • 11.3.8.4. Strategic initiatives
  • 11.3.9. Smith+Nephew
    • 11.3.9.1. Company overview
    • 11.3.9.2. Financial performance
    • 11.3.9.3. Product benchmarking
    • 11.3.9.4. Strategic initiatives
  • 11.3.10. B. Braun SE
    • 11.3.10.1. Company overview
    • 11.3.10.2. Financial performance
    • 11.3.10.3. Product benchmarking
    • 11.3.10.4. Strategic initiatives
  • 11.3.11. DermaRite Industries, LLC.
    • 11.3.11.1. Company overview
    • 11.3.11.2. Financial performance
    • 11.3.11.3. Product benchmarking
    • 11.3.11.4. Strategic initiatives
  • 11.3.12. Integra LifeSciences Corporation.
    • 11.3.12.1. Company overview
    • 11.3.12.2. Financial performance
    • 11.3.12.3. Product benchmarking
    • 11.3.12.4. Strategic initiatives
  • 11.3.13. Axio Biosolutions Private Limited
    • 11.3.13.1. Company overview
    • 11.3.13.2. Financial performance
    • 11.3.13.3. Product benchmarking
    • 11.3.13.4. Strategic initiatives
  • 11.3.14. Sanara MedTech Inc.
    • 11.3.14.1. Company overview
    • 11.3.14.2. Financial performance
    • 11.3.14.3. Product benchmarking
    • 11.3.14.4. Strategic initiatives
• 11.4. Heat Map Analysis/ Company Market Position Analysis
• 11.5. Estimated Company Market Share Analysis, 2024
• 11.6. List of Other Key Market Players